247 related articles for article (PubMed ID: 11258122)
61. Posterior capsular opacification and intraocular lens decentration. Part II: Experimental findings on a prototype circular intraocular lens design.
Tetz MR; O'Morchoe DJ; Gwin TD; Wilbrandt TH; Solomon KD; Hansen SO; Apple DJ
J Cataract Refract Surg; 1988 Nov; 14(6):614-23. PubMed ID: 3230514
[TBL] [Abstract][Full Text] [Related]
62. Early posterior capsular opacification after intercapsular cataract extraction and rigid Galand disc intraocular lens implantation.
Gunning FP; Greve EL
J Cataract Refract Surg; 1992 Jul; 18(4):366-9. PubMed ID: 1501089
[TBL] [Abstract][Full Text] [Related]
63. Interlenticular opacification associated with asymmetric haptic fixation of the anterior intraocular lens.
Jackson DW; Koch DD
Am J Ophthalmol; 2003 Jan; 135(1):106-8. PubMed ID: 12504714
[TBL] [Abstract][Full Text] [Related]
64. The effect of the haptic portion of intraocular lens on the development of posterior capsular opacification in rabbit.
Yoon YD; Lim SJ; Kim HB
Yonsei Med J; 1999 Jun; 40(3):232-7. PubMed ID: 10412334
[TBL] [Abstract][Full Text] [Related]
65. Pathogenesis of posterior capsular opacification. Part I. Epidemiological and clinico-statistical data.
Frezzotti R; Caporossi A
J Cataract Refract Surg; 1990 May; 16(3):347-52. PubMed ID: 2355323
[TBL] [Abstract][Full Text] [Related]
66. Experimental models for posterior capsule opacification research.
Wormstone IM; Eldred JA
Exp Eye Res; 2016 Jan; 142():2-12. PubMed ID: 25939555
[TBL] [Abstract][Full Text] [Related]
67. Prevention of posterior capsular opacification.
Nibourg LM; Gelens E; Kuijer R; Hooymans JM; van Kooten TG; Koopmans SA
Exp Eye Res; 2015 Jul; 136():100-15. PubMed ID: 25783492
[TBL] [Abstract][Full Text] [Related]
68. Posterior capsule opacification: What's in the bag?
Wormstone IM; Wormstone YM; Smith AJO; Eldred JA
Prog Retin Eye Res; 2021 May; 82():100905. PubMed ID: 32977000
[TBL] [Abstract][Full Text] [Related]
69. Cell biology of posterior capsular opacification.
Marcantonio JM; Vrensen GF
Eye (Lond); 1999 Jun; 13 ( Pt 3b)():484-8. PubMed ID: 10627829
[TBL] [Abstract][Full Text] [Related]
70. RGD surface functionalization of the hydrophilic acrylic intraocular lens material to control posterior capsular opacification.
Huang YS; Bertrand V; Bozukova D; Pagnoulle C; Labrugère C; De Pauw E; De Pauw-Gillet MC; Durrieu MC
PLoS One; 2014; 9(12):e114973. PubMed ID: 25501012
[TBL] [Abstract][Full Text] [Related]
71. A 3D in vitro model for assessing the influence of intraocular lens: Posterior lens capsule interactions on lens epithelial cell responses.
Izuagbe S; Roy J; Chatila A; Hoang LQ; Ea V; Vaish B; Co CM; Ly A; Wu H; Tang L
Exp Eye Res; 2024 Jul; 244():109940. PubMed ID: 38782178
[TBL] [Abstract][Full Text] [Related]
72. Experimental lens capsular bag model for posterior capsule opacification.
Jun JH; Sohn WJ; Lee Y; Chang SD; Kim JY
Cell Tissue Res; 2014 Jul; 357(1):101-8. PubMed ID: 24793776
[TBL] [Abstract][Full Text] [Related]
73. Lens capsule opacification in aphakic and pseudophakic eyes.
Nasisse MP; Dykstra MJ; Cobo LM
Graefes Arch Clin Exp Ophthalmol; 1995 Feb; 233(2):63-70. PubMed ID: 7729705
[TBL] [Abstract][Full Text] [Related]
74. Erufosine, a phosphoinositide-3-kinase inhibitor, to mitigate posterior capsule opacification in the human capsular bag model.
Wertheimer C; Brandlhuber U; Kook D; Mayer WJ; Laubichler P; Wolf A; Kampik A; Eibl-Lindner K
J Cataract Refract Surg; 2015 Jul; 41(7):1484-9. PubMed ID: 26210048
[TBL] [Abstract][Full Text] [Related]
75. The intraocular lens as a drug delivery device for an epidermal growth factor-Receptor inhibitor for prophylaxis of posterior capsule opacification.
Wertheimer C; Kueres A; Siedlecki J; Braun C; Kassumeh S; Wolf A; Mayer W; Priglinger C; Priglinger S; Eibl-Lindner K
Acta Ophthalmol; 2018 Nov; 96(7):e874-e882. PubMed ID: 29855160
[TBL] [Abstract][Full Text] [Related]
76. [Influence of intraocular lens material and design on the development of posterior capsule opacification].
Nishi O
Ophthalmologe; 2005 Jun; 102(6):572-8. PubMed ID: 15895236
[TBL] [Abstract][Full Text] [Related]
77. [Pathogenesis of posterior capsule opacification in pseudophakia].
Łukaszewska-Smyk A; Kałuzny J
Klin Oczna; 2009; 111(10-12):369-74. PubMed ID: 20169899
[TBL] [Abstract][Full Text] [Related]
78. Anti-Adhesive And Antiproliferative Synergistic Surface Modification Of Intraocular Lens For Reduced Posterior Capsular Opacification.
Han Y; Tang J; Xia J; Wang R; Qin C; Liu S; Zhao X; Chen H; Lin Q
Int J Nanomedicine; 2019; 14():9047-9061. PubMed ID: 31819418
[TBL] [Abstract][Full Text] [Related]
79. [Study on inhibitory effects of matrix metalloproteinase inhibitor on migration of cultured human lens epithelial cells].
Li JH; Chen FH; Wang NL
Zhonghua Yan Ke Za Zhi; 2008 Apr; 44(4):315-20. PubMed ID: 18844017
[TBL] [Abstract][Full Text] [Related]
80. MMP inhibition prevents human lens epithelial cell migration and contraction of the lens capsule.
Wong TT; Daniels JT; Crowston JG; Khaw PT
Br J Ophthalmol; 2004 Jul; 88(7):868-72. PubMed ID: 15205227
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
